(MENAFN- PR Newswire)
NEW YORK, Jan. 25, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Maxar Technologies Inc. (NYSE: maxr )'s
sale to Advent International for $53.00 per share in cash. If you are a Maxar shareholder, click here to learn more about your legal rights and options .
Sesen Bio, Inc. (NASDAQ: sesn )'s
Carisma Therapeutics Inc. Pre-merger Sesen Bio shareholders are expected to own approximately 41.7% of the combined company. If you are a Sesen Bio shareholder, click here to learn more about your rights and options .
Imara Inc. (NASDAQ: imra )'s
merger with Enliven Therapeutics, Inc. If you are an Imara shareholder, click here to learn more about your rights and options .
Elevate Credit, Inc. (NYSE: elvt )'s
sale to an affiliate of Park Cities Asset Management LLC for $1.87 per share.
If you are an Elevate Credit shareholder, click here to learn more about your rights and options .
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected]
or [email protected] .
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
SOURCE Halper Sadeh LLP
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.